Synthesis of a Series of Novel 2-Amino-5-substituted 1,3,4-oxadiazole and 1,3,4-thiadiazole Derivatives as Potential Anticancer, Antifungal and Antibacterial Agents. 2022

Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
Department of Organic Chemistry, Faculty of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh city, 700000 Ho Chi Minh city, Viet Nam.

BACKGROUND Many compounds containing a five-membered heterocyclic ring display exceptional chemical properties and versatile biological activities. OBJECTIVE The objective of the present study was to prepare the 5-substituted 2-amino-1,3,4- oxadiazole and 2-amino-1,3,4-thiadiazole derivatives and evaluate their potential anticancer, antibacterial and antifungal activities. METHODS Twenty-seven derivatives were synthesized by iodine-mediated cyclization of semicarbazones or thiosemicarbazones obtained from condensation of semicarbazide or thiosemicarbazide and aldehydes. The structures were confirmed by 1H-NMR, 13C-NMR and MS spectra. The antibacterial and antifungal activities were evaluated by diffusion method and the anticancer activities were evaluated by MTT assay. RESULTS Twenty-seven derivatives have been synthesized in moderate to good yields. A number of derivatives exhibited potential antibacterial, antifungal and anticancer activities. CONCLUSIONS Compounds (1b, 1e and 1g) showed antibacterial activity against Streptococcus faecalis, MSSA and MRSA with MIC value ranging between 4 to 64 μg/mL. Compound (2g) showed antifungal activity against Candida albicans (8 μg/mL) and Aspergillus niger (64 μg/mL). Compound (1o) exhibited high cytotoxic activity against HepG2 cell line (IC50 value 8.6 μM) which is comparable to the activity of paclitaxel, and is non-toxic on LLC-PK1 normal cell line. The structure activity relationship and molecular docking study of the synthesized compounds have also been reported.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010069 Oxadiazoles Compounds containing five-membered heteroaromatic rings containing two carbons, two nitrogens, and one oxygen atom which exist in various regioisomeric forms. Oxadiazole
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013830 Thiadiazoles Heterocyclic compounds composed of a five-membered heterocyclic ring which contains one sulfur and two nitrogen atoms. Thiadiazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
April 2012, Chemical biology & drug design,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
January 2018, Anti-cancer agents in medicinal chemistry,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
April 2008, Bioorganic & medicinal chemistry,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
July 2016, Journal of chemical biology,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
February 2006, Bioorganic & medicinal chemistry,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
January 2010, Acta poloniae pharmaceutica,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
May 2020, Bioorganic & medicinal chemistry letters,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
August 2015, Bioorganic & medicinal chemistry,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
June 2007, Bioorganic & medicinal chemistry,
Em Canh Pham, and Tuyen Ngoc Truong, and Nguyen Hanh Dong, and Duy Duc Vo, and Tuoi Thi Hong Do
April 2024, ACS omega,
Copied contents to your clipboard!